E3 Ubiquitin Ligase System in Neurodegeneration

Migration, Crosslink

📖

E3 Ubiquitin Ligase System in Neurodegeneration

active

wiki page Created: 2026-04-02T07:20:00 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-e3-ubiquitin-ligase-syst

📖 Wiki Page

mechanism2150 wordssynced 2026-04-02

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

The E3 ubiquitin ligase system represents the substrate-specific arm of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system), playing a critical role in [protein quality control](/mechanisms/protein-quality-control-network), cellular homeostasis, and the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), and [frontotemporal dementia](/diseases/frontotemporal-dementia). E3 ligases catalyze the covalent attachment of ubiquitin to target proteins, determining both the specificity and fate of ubiquitinated substrates. With over 600 known E3 ligases in the human genome, these enzymes represent the largest family of ubiquitin-related proteins and offer numerous therapeutic targets for neurodegenerative disease intervention [@komander2012].

This page provides comprehensive coverage of the three major E3 ligase families (RING, HECT, and RBR), their roles in neurodegeneration, and the emerging therapeutic potential of targeted protein degradation through PROTACs [@deshaies2009].

E3 Ubiquitin Ligase Families

...

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

The E3 ubiquitin ligase system represents the substrate-specific arm of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system), playing a critical role in [protein quality control](/mechanisms/protein-quality-control-network), cellular homeostasis, and the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), and [frontotemporal dementia](/diseases/frontotemporal-dementia). E3 ligases catalyze the covalent attachment of ubiquitin to target proteins, determining both the specificity and fate of ubiquitinated substrates. With over 600 known E3 ligases in the human genome, these enzymes represent the largest family of ubiquitin-related proteins and offer numerous therapeutic targets for neurodegenerative disease intervention [@komander2012].

This page provides comprehensive coverage of the three major E3 ligase families (RING, HECT, and RBR), their roles in neurodegeneration, and the emerging therapeutic potential of targeted protein degradation through PROTACs [@deshaies2009].

E3 Ubiquitin Ligase Families

E3 ubiquitin ligases are classified into three major families based on their mechanistic properties and structural characteristics: [RING](/proteins/ring-finger-proteins) (Really Interesting New Gene), [HECT](/proteins/hect-domain-ubiquitin-ligases) (Homologous to E6-AP Carboxyl Terminus), and [RBR](/proteins/rbr-family-ligases) (RING-in-Between-RING).

RING (Really Interesting New Gene) Family

The RING family represents the largest class of E3 ligases, characterized by a RING finger domain that directly mediates ubiquitin transfer from E2 to substrate. Unlike HECT ligases, RING ligases do not form covalent intermediates with ubiquitin.

Key RING ligases in neurodegeneration [@kaelin2008]:

MARCH7 (Membrane-Associated Ring-CH-Type Finger 7): Involved in immune regulation and neuronal development
MARCH5: Mitochondrial outer membrane ligase involved in mitochondrial quality control
TRIM proteins (TRIM2, TRIM3, TRIM9, TRIM11, TRIM32): Tripartite motif-containing proteins with diverse neuronal functions
VHL (Von Hippel-Lindau): Critical tumor suppressor and E3 ligase targeted by PROTACs [@kaelin2008]
RNF182, RNF10, RNF13, RNF14: Ring finger proteins with documented roles in neuronal survival

HECT (Homologous to E6-AP Carboxyl Terminus) Family

The HECT family consists of approximately 30 E3 ligases characterized by a conserved C-terminal HECT domain. Unlike RING ligases, HECT enzymes form a thioester intermediate with ubiquitin before transferring it to the substrate [@weber2022].

Key HECT ligases in neurodegeneration [@huwe2023]:

HUWE1 (HECT and WD Repeat Domain-Containing Protein 1): One of the largest E3 ligases, involved in DNA damage response and amyloid precursor protein (APP) processing
UBE3A (also known as E6-AP): Imprinted gene critical for neuronal function; mutations cause Angelman syndrome [@mabb2010]
NEDD4 (Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 4): Regulates synaptic protein turnover
SMURF1/2: Autophagy regulators with roles in protein clearance
WWP2: Regulates PTEN and other neuronal survival proteins

RBR (RING-in-Between-RING) Family

The RBR family represents a hybrid mechanism, combining features of both RING and HECT ligases. These enzymes contain two RING fingers (RING1 and RING2) separated by an in-between region (IBR), followed by a HECT-like domain. RBR ligases use a "tricky hand" mechanism where ubiquitin is transferred from the RING1-bound E2 to an active site cysteine on the RING2 domain before substrate modification [@rbr2013].

Key RBR ligases in neurodegeneration [@rbr2013]:

Parkin (encoded by PRKN): The most studied RBR ligase, essential for mitophagy and mitochondrial quality control [@pickrell2015]
HHARI (also known as ARH1): Closest relative of Parkin with overlapping functions
RNF144: Membrane-anchored RBR ligases with neuronal expression

Key E3 Ligases in Neurodegeneration

Parkin (PARK2)

Parkin is an RBR E3 ubiquitin ligase encoded by the [PRKN](/genes/prkn) gene, one of the most frequently mutated genes in early-onset autosomal recessive [Parkinson's disease](/diseases/parkinsons-disease). Parkin functions as a central coordinator of mitochondrial quality control through [mitophagy](/mechanisms/mitophagy).

Mechanism of Action [@kitada1998]:

In healthy mitochondria, Parkin remains cytosolic in an autoinhibited state

Upon mitochondrial damage, [PINK1](/genes/pink1) (PTEN-induced kinase 1) accumulates on the outer mitochondrial membrane

PINK1 phosphorylates both ubiquitin and Parkin, activating its E3 ligase activity

Activated Parkin ubiquitinates outer mitochondrial membrane proteins

Ubiquitinated mitochondria are targeted for [autophagic](/mechanisms/autophagy-lysosomal-pathway) degradation

Role in Disease:

PRKN mutations cause loss of mitophagy function
Impaired mitochondrial quality control leads to [dopaminergic neuron](/cell-types/dopaminergic-neurons) death
Parkin dysfunction contributes to the pathogenesis of both familial and sporadic [Parkinson's disease](/diseases/parkinsons-disease)

CHIP/STUB1

CHIP (C-terminus of Hsp70-interacting protein), encoded by the [STUB1](/genes/stub1) gene, is a U-box E3 ligase that integrates molecular chaperone function with protein degradation. CHIP coordinates the turnover of misfolded proteins and regulates cellular stress responses.

Key Functions:

Recognizes Hsp70/Hsp90-bound misfolded proteins
Facilitates ubiquitination and proteasomal degradation of client proteins
Regulates autophagy of damaged proteins
Modulates inflammation signaling pathways

Role in Disease:

CHIP dysfunction impairs clearance of misfolded proteins in [Alzheimer's disease](/diseases/alzheimers-disease)
Regulates [tau](/proteins/tau) ubiquitination and degradation
Protects against [ALS](/diseases/amyotrophic-lateral-sclerosis) by clearing [TDP-43](/proteins/tdp-43-protein) aggregates

TRIM Proteins in Neurodegeneration

The TRIM (Tripartite Motif) family comprises over 70 proteins with diverse functions in neuronal development, [protein quality control](/mechanisms/protein-quality-control-network), and antiviral immunity.

Key TRIM ligases:

[TRIM2](/genes/trim2): Regulates neurotrophin receptor trafficking; mutations cause Charcot-Marie-Tooth disease
[TRIM3](/genes/trim3): Presynaptic protein regulating synaptic function
[TRIM9](/genes/trim9): Involved in synaptic vesicle trafficking and neuronal polarity
[TRIM11](/genes/trim11): Regulates protein aggregation in neurodegeneration
TRIM17: Regulates neuronal apoptosis
TRIM28 (also known as KAP1): Transcriptional regulator with roles in DNA damage response
TRIM32: Mutations cause limb-girdle muscular dystrophy; regulates aggresome formation

MARCH7

MARCH7 is a membrane-associated RING finger E3 ligase expressed predominantly in immune cells and [neurons](/cell-types/neurons). It plays roles in immune regulation and neuronal development, though its specific functions in neurodegeneration remain under investigation.

E3 Ligase Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

In [Alzheimer's disease](/diseases/alzheimers-disease), E3 ligase dysfunction contributes to the accumulation of toxic protein aggregates, including [amyloid-beta](/proteins/amyloid-beta-protein) plaques and [neurofibrillary tangles](/mechanisms/neurofibrillary-tangles) composed of hyperphosphorylated [tau](/proteins/tau).

Key Mechanisms:

APP Processing: HUWE1 and NEDD4 regulate amyloid precursor protein (APP) processing and amyloid-beta production
Tau Degradation: CHIP, Parkin, and TRAF6 participate in tau ubiquitination; impaired clearance leads to NFT formation
Synaptic Protein Turnover: Dysregulated E3 ligase activity disrupts synaptic protein homeostasis
Neuroinflammation: RING finger proteins regulate NF-κB signaling pathways

Parkinson's Disease

[Parkinson's disease](/diseases/parkinsons-disease) is uniquely linked to E3 ligase dysfunction, particularly in mitochondrial quality control pathways.

Key Mechanisms:

[PINK1](/genes/pink1)/[Parkin](/proteins/parkin-protein) Pathway: Mutations in both genes cause early-onset PD
Mitochondrial Dynamics: MARCH5 and other mitochondrial E3 ligases regulate mitochondrial fission/fusion
[α-Synuclein](/proteins/alpha-synuclein) Degradation: E3 ligases including CHIP and Parkin contribute to α-synuclein clearance
Lysosomal Function: RING ligases regulate lysosomal protein trafficking

Amyotrophic Lateral Sclerosis (ALS)

In [ALS](/diseases/amyotrophic-lateral-sclerosis), E3 ligase dysfunction contributes to the accumulation of misfolded proteins including [SOD1](/proteins/sod1-protein), [TDP-43](/proteins/tdp-43-protein), and [FUS](/proteins/fused-in-sarcoma).

Key Mechanisms:

SOD1 Degradation: CHIP and Parkin regulate mutant SOD1 clearance
TDP-43 Pathology: E3 ligases regulate TDP-43 ubiquitination and degradation
Autophagy Regulation: Multiple E3 ligases coordinate aggrephagy
RNA Metabolism: UBE3A and other ligases regulate RNA-binding protein homeostasis

Frontotemporal Dementia (FTD)

[FTD](/diseases/frontotemporal-dementia) involves E3 ligase dysfunction affecting protein clearance and neuronal survival.

Key Mechanisms:

[Tau](/proteins/tau) Pathology: Similar to AD, impaired tau clearance
[TDP-43](/proteins/tdp-43-protein) Inclusions: E3 ligase-mediated degradation pathways are impaired
Granulin Regulation: Progranulin deficiency affects [lysosomal](/mechanisms/lysosomal-dysfunction) function
Chromatin Regulation: TRIM28/KAP1 dysfunction affects gene expression

PROTACs and Targeted Protein Degradation

[PROTACs](/therapeutics/proteolysis-targeting-chimeras) (PROteolysis TArgeting Chimeras) represent a revolutionary therapeutic paradigm that exploits the cellular [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) to eliminate disease-causing proteins. These bifunctional molecules recruit E3 ligases to target proteins, leading to their ubiquitination and subsequent proteasomal degradation [@bondeson2017].

Cereblon (CRBN)

Cereblon is a substrate receptor of the CRL4 E3 ligase complex, originally identified as the target of immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide [@ito2010].

Therapeutic Applications:

Multiple myeloma treatment via degradation of IKZF1/3
Emerging applications in neurodegenerative disease
Potential for degrading disease-causing proteins

VHL (Von Hippel-Lindau)

The VHL tumor suppressor forms part of the CRL2 E3 ligase complex and is one of the most frequently used E3 ligases in PROTAC design due to its high targetability and tissue distribution [@bondeson2017].

Therapeutic Applications:

Extensive PROTAC development for cancer therapy
Potential for CNS drug delivery
Validation in animal models

Other E3 Ligases for PROTAC Development

DCAF15: Target of sulfonamide drugs
RNF4: Polycomb proteins and transcriptional regulators
Cereblon (CRBN): Most successful for hematologic malignancies

Cullin-RING Ligase Complexes

The Cullin-RING ligase (CRL) family represents the largest class of E3 ligases, comprising approximately 250 members [@petroski2005]. These multisubunit complexes consist of:

Cullin scaffold (CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, CUL7)

RING box protein (Rbx1/RNF7) that recruits the E2 enzyme

Adaptor proteins that confer substrate specificity

Substrate receptors that recognize target proteins

Key CRL complexes in neurodegeneration:

CRL4: Includes DCAF proteins; mutations in CRBN (CRL4 substrate receptor) linked to intellectual disability
CRL2: Includes VHL; targetable for PROTAC development
CUL3: Mutations cause familial ALS and psychiatric disorders [@teyra2019]

Therapeutic Opportunities

E3 Ligase Activators

Small molecule activators:

Parkin activators for PD (e.g., ursodeoxycholic acid)
CHIP enhancers for protein aggregate clearance

E3 Ligase Inhibitors

Therapeutic inhibition:

Inappropriate for most neurodegenerative applications
May be useful in specific contexts where E3 ligase activity is pathogenic

PROTAC Development for Neurodegeneration

Target proteins for degradation:

Mutant huntingtin protein (HTT)
Tau protein aggregates
α-synuclein oligomers
Mutant SOD1
TDP-43 aggregates

Challenges:

Blood-brain barrier penetration
E3 ligase expression in the CNS
Selectivity and safety

Gene Therapy Approaches

Viral vector delivery of functional E3 ligase genes
CRISPR-based correction of loss-of-function mutations
siRNA-mediated knockdown of pathogenic E3 ligases

Visual Summary

Mermaid diagram (expand to render)

E3 Ligases in Neurodegenerative Diseases

| E3 Ligase | Substrates | Disease | Function |
|-----------|-----------|---------|----------|
| Parkin | Mitofusins, VDAC | PD | Mitochondrial quality control |
| VHL | HIF-1α | AD | Hypoxia response |
| MUL1 | MFN1/2 | PD | Mitochondrial dynamics |
| TRIM proteins | Various | ALS, PD | Protein clearance |
| CHIP | Tau, α-syn | AD, PD | Protein quality control |
| TRAF6 | NF-κB | AD, PD | Neuroinflammation |

The E3 ubiquitin ligase system is intimately connected to other cellular pathways:

[Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) — the broader system of which E3 ligases are a part
[Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) — complementary protein clearance pathway
[PINK1-Parkin Mitophagy Pathway](/mechanisms/pink1-parkin-pathway) — Parkin-mediated mitochondrial quality control
[Proteostasis Network](/mechanisms/proteostasis-neurodegeneration) — cellular protein homeostasis

Gene and Protein Pages

For detailed information on specific E3 ligases, refer to:

[PRKN (Parkin) Gene](/genes/prkn) — Parkin RBR E3 Ubiquitin Protein Ligase
[Parkin Protein](/proteins/parkin-protein)
[STUB1/CHIP Gene](/genes/stub1) — C-terminus of Hsp70-interacting protein
[CHIP Protein](/proteins/chip-protein)
[HUWE1 Gene](/genes/huwe1) — HECT and WD Repeat Domain-Containing Protein 1
[MARCH7 Gene](/genes/march7) — Membrane Associated Ring-CH Type Finger 7
[MARCH5 Gene](/genes/march5) — Mitochondrial E3 Ubiquitin Protein Ligase
[VHL Gene](/genes/vhl) — Von Hippel-Lindau Tumor Suppressor
[TRIM2 Gene](/genes/trim2)
[TRIM32 Gene](/genes/trim32)
[CUL3 Gene](/genes/cul3) — Cullin 3

Conclusion

The E3 ubiquitin ligase system represents a critical nexus for protein quality control in the nervous system. With over 600 members, these enzymes provide exquisite specificity in targeting proteins for degradation or modifying their function. Dysfunction of specific E3 ligases—including Parkin, CHIP, and various TRIM proteins—contributes to the pathogenesis of major neurodegenerative diseases including Alzheimer's, Parkinson's, ALS, and FTD.

The emergence of PROTAC technology has transformed our ability to exploit E3 ligases therapeutically, offering new avenues for treating neurodegenerative diseases by selectively degrading disease-causing proteins. Continued research into E3 ligase biology promises to reveal additional therapeutic targets and strategies for maintaining neuronal protein homeostasis.

External Links

[Ubiquitin Database](https://ubiquibindb.org/) — Comprehensive ubiquitin-related information
[PROTAC Database](http://protac.cancerpharma.cn/) — PROTAC and molecular glue database

References

[Komander D, Rape M. The ubiquitin code (2012)](https://doi.org/10.1146/annurev-biochem-060310-170328)

[Deshaies RJ, Joazeiro CA. RING domain E3 ubiquitin ligases (2009)](https://doi.org/10.1146/annurev.biochem.78.101807.093809)

[Weber J, et al. HECT E3 ubiquitin ligases (2022)](https://doi.org/10.1242/jcs.245712)

[Huwe H, et al. HUWE1 in the central nervous system (2023)](https://doi.org/10.1007/s10571-023-01342-8)

[Mabb AM, Ehlers MD. Ubiquitin in neuronal development and function (2010)](https://doi.org/10.1016/j.neuron.2010.03.015)

[Rieser E, et al. RBR family of E3 ubiquitin ligases (2013)](https://doi.org/10.1038/embor.2013.233)

[Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease (2015)](https://doi.org/10.1016/j.neuron.2014.12.007)

[Kitada T, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism (1998)](https://doi.org/10.1038/33419)

[Ballinger CA, et al. Identification of CHIP (1999)](https://doi.org/10.1128/MCB.19.6.4535)

[Hatakeyama S, et al. TRIM proteins and cancer (2011)](https://doi.org/10.1038/nrc3139)

[Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases (2015)](https://doi.org/10.1038/emm.2014.117)

[Bondeson DP, Crews CM. Targeted protein degradation by PROTACs (2017)](https://doi.org/10.1146/annurev-pharmtox-010715-103523)

[Petroski MD, Deshaies RJ. Function and regulation of cullin-RING ubiquitin ligases (2005)](https://doi.org/10.1038/nrm1547)

[Teyra J, et al. CUL3 mutations in ALS and FTD (2019)](https://doi.org/10.1073/pnas.1818828116)

[Sakamoto KM, et al. Development of PROTACs (2001)](https://doi.org/10.1158/1535-7163.1.2.93)

[Ito T, et al. Identification of cereblon as thalidomide target (2010)](https://doi.org/10.1126/science.1177319)

[Baldwin KR, et al. Protein homeostasis in ALS (2022)](https://doi.org/10.1186/s13024-022-00539-7)

[Rohan Z, et al. Molecular mechanisms of neurodegeneration in FTD (2023)](https://doi.org/10.1038/s41582-023-00849-w)

[Kaelin WG. The von Hippel-Lindau tumour suppressor protein (2008)](https://doi.org/10.1038/nrc2502)

📖 View canonical wiki page →

Related Entities

mechanisms-e3-ubiquitin-ligase-system

▸Metadataorigin_type: v1_polymorphic_backfill

slug	mechanisms-e3-ubiquitin-ligase-system
kg_node_id	None
entity_type	mechanism
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-fcd03a3162de
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-e3-ubiquitin-ligase-system'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

548

Outgoing

708

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

E3 Ubiquitin Ligase System in Neurodegeneration

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

E3 Ubiquitin Ligase Families

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

E3 Ubiquitin Ligase Families

RING (Really Interesting New Gene) Family

HECT (Homologous to E6-AP Carboxyl Terminus) Family

RBR (RING-in-Between-RING) Family

Key E3 Ligases in Neurodegeneration

Parkin (PARK2)

CHIP/STUB1

TRIM Proteins in Neurodegeneration

MARCH7

E3 Ligase Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

PROTACs and Targeted Protein Degradation

Cereblon (CRBN)

VHL (Von Hippel-Lindau)

Other E3 Ligases for PROTAC Development

Cullin-RING Ligase Complexes

Therapeutic Opportunities

E3 Ligase Activators

E3 Ligase Inhibitors

PROTAC Development for Neurodegeneration

Gene Therapy Approaches

Visual Summary

E3 Ligases in Neurodegenerative Diseases

Gene and Protein Pages

Conclusion

See Also

External Links

References

💬 Discussion

📗 Cite This Artifact

E3 Ubiquitin Ligase System in Neurodegeneration

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

E3 Ubiquitin Ligase Families

E3 Ubiquitin Ligase System in Neurodegeneration

Introduction

E3 Ubiquitin Ligase Families

RING (Really Interesting New Gene) Family

HECT (Homologous to E6-AP Carboxyl Terminus) Family

RBR (RING-in-Between-RING) Family

Key E3 Ligases in Neurodegeneration

Parkin (PARK2)

CHIP/STUB1

TRIM Proteins in Neurodegeneration

MARCH7

E3 Ligase Dysfunction in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Frontotemporal Dementia (FTD)

PROTACs and Targeted Protein Degradation

Cereblon (CRBN)

VHL (Von Hippel-Lindau)

Other E3 Ligases for PROTAC Development

Cullin-RING Ligase Complexes

Therapeutic Opportunities

E3 Ligase Activators

E3 Ligase Inhibitors

PROTAC Development for Neurodegeneration

Gene Therapy Approaches

Visual Summary

E3 Ligases in Neurodegenerative Diseases

Cross-Links to Related Mechanisms

Gene and Protein Pages

Conclusion

See Also

External Links

References

💬 Discussion